Efficacy of recombinant erythropoietin for the late treatment of anemia of prematurity in a level IV neonatal intensive care unit: a retrospective single-center cohort study

Villeneuve A, Arsenault V, Lacroix J, Tucci M. Neonatal red blood cell transfusion. Vox Sang. 2021;116:366–78.

Article  PubMed  Google Scholar 

Bell EF. Red cell transfusion thresholds for preterm infants: finally some answers. Arch Dis Child Fetal Neonatal Ed. 2022;107:126–30.

Article  PubMed  Google Scholar 

Colobatti R, Sainati L, Trevisanuto D. Anemia and transfusion in the neonate. Semin Fetal Neonatal Med. 2016;21:2–9.

Article  Google Scholar 

Christensen RD, Baer VL, Lambert DK, Ilstrup SJ, Eggert LD, Henry E. Association, among very-low birthweight neonates, between red blood cell transfusions in the week after birth and severe intraventricular hemorrhage. Transfusion. 2014;54:104–8.

Article  PubMed  Google Scholar 

Ohlsson A, Aher SM. Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Database Syst Rev. 2017;11:CD004863.

PubMed  Google Scholar 

Ohlsson A, Aher SM. Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;1:CD004868.

PubMed  Google Scholar 

Maier RF, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin β ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000g. J Pediatr. 2002;141:8–15.

Article  CAS  PubMed  Google Scholar 

El-Lahony DM, Saleh NY, Habib MS, Shehata MA, El-Hawy MA. The role of recombinant human erythropoietin in neonatal anemia. Hematol Oncol Stem Cell Ther. 2020;13:147–51.

Article  PubMed  Google Scholar 

Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr. 1995;126:421–6.

Article  CAS  PubMed  Google Scholar 

Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double blind, placebo-controlled study. J Pediatr. 1997;131:661–5.

Article  CAS  PubMed  Google Scholar 

Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics. 2001;108:934–42.

Article  CAS  PubMed  Google Scholar 

Juul SE, Vu PT, Comstock BA, Wadhawan R, Mayock DE, Courtney SE, et al. Effect of high-dose erythropoietin on blood transfusions in extremely low gestational age neonates: post hoc analysis of a randomized clinical trial. JAMA Pediatr. 2020;174:933–43.

Article  PubMed  Google Scholar 

Salsbury DC. Anemia of prematurity. Neonatal Netw. 2001;20:13–20.

Article  CAS  PubMed  Google Scholar 

Strauss RG. Anemia of prematurity: pathophysiology & treatment. Blood Rev. 2010;24:221–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Romagnoli C, Zecca E, Gallini F, Zuppa PGAA. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr. 2000;159:627–34.

Article  CAS  PubMed  Google Scholar 

Fischer HS, Reibel NJ, Bührer C, Dame C. Effect of early erythropoietin on retinopathy of prematurity: a stratified meta-analysis. Neonatology. 2023;120:566–76.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif